Aethlon Medical (AEMD) Expected to Announce Quarterly Earnings on Wednesday

Aethlon Medical (NASDAQ:AEMD) is projected to announce its earnings results after the market closes on Wednesday, February 12th. Analysts expect the company to announce earnings of ($0.22) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Aethlon Medical Stock Down 6.2 %

Shares of AEMD opened at $0.68 on Tuesday. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $1.85. The stock has a market cap of $9.49 million, a PE ratio of -0.24 and a beta of 1.88. The firm’s fifty day moving average is $0.61 and its two-hundred day moving average is $0.47.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on AEMD shares. StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Monday, January 27th. They set a “sell” rating on the stock. HC Wainwright restated a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a report on Thursday, January 30th.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.